2024 CAP/IASLC/AMP Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors Guideline Update

Working Group Speaker(s)

• 

  Dhananjay A. Chitale, MD, MBA (he/him/his)

  Vice Chair, Anatomic Pathology, Division Head Molecular Pathology and Genomic Medicine
  Henry Ford Health
  Detroit, Michigan, United States